Novel Labs Inc Company Profile
✉ Email this page to a colleague
What is the competitive landscape for NOVEL LABS INC, and what generic and branded alternatives to NOVEL LABS INC drugs are available?
NOVEL LABS INC has fifty-six approved drugs.
There are three tentative approvals on NOVEL LABS INC drugs.
Summary for Novel Labs Inc
| US Patents: | 0 |
| Tradenames: | 42 |
| Ingredients: | 41 |
| NDAs: | 56 |
Drugs and US Patents for Novel Labs Inc
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Novel Labs Inc | PEG 3350 AND ELECTROLYTES | polyethylene glycol 3350; potassium chloride; sodium bicarbonate; sodium chloride; sodium sulfate anhydrous | FOR SOLUTION;ORAL | 090186-001 | Jun 1, 2009 | RX | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Novel Labs Inc | SULFAMETHOPRIM | sulfamethoxazole; trimethoprim | TABLET;ORAL | 070022-001 | Feb 15, 1985 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| Novel Labs Inc | HYDROCODONE BITARTRATE AND ACETAMINOPHEN | acetaminophen; hydrocodone bitartrate | TABLET;ORAL | 206245-002 | Dec 1, 2016 | DISCN | No | No | ⤷ Subscribe | ⤷ Subscribe | |||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.
Here is a list of applicants with similar names.
